{"title": "Las cuatro grandes farmac\u00e9uticas de la covid ganaron 90.000 millones con las vacunas", "author": "Lidia Ram\u00edrez Rold\u00e1n", "url": "https://theobjective.com/economia/2023-06-22/cuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas/", "hostname": "theobjective.com", "description": "Las cuatro grandes farmac\u00e9uticas productoras de vacunas covid, Pfizer, BioNTech, Moderna y Sinovac, han vivido varios a\u00f1os de oro gracias a los ingresos", "sitename": "The Objective", "date": "2023-06-22", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Las cuatro grandes farmac\u00e9uticas de la covid ganaron 90.000 millones con las vacunas\nLos siete mayores laboratorios de inyecciones contra el coronavirus recibieron 5.800 millones de fondos gubernamentales\nLas cuatro\n[grandes farmac\u00e9uticas productoras de vacunas covid,](https://theobjective.com/espana/politica/2023-04-02/bruselas-renegocia-contratos-vacunas-covid-superavit/) Pfizer, BioNTech, Moderna y Sinovac, han vivido varios a\u00f1os de oro gracias a los ingresos generados con su inyecciones contra el coronavirus. Estas empresas obtuvieron beneficios de hasta 90.000 millones de d\u00f3lares durante 2021 y 2022 por sus productos relacionados con la covid-19, seg\u00fan un informe del Centro de Investigaciones Multinacionales SOMO, con sede en Holanda, consultado por [THE OBJECTIVE.](https://theobjective.com/) De esta forma, este estudio sit\u00faa a Pfizer (35.000 millones), BioNTech (20.000), Moderna (20.000 millones) y Sinovac (15.000 millones) como los laboratorios que m\u00e1s dinero han ganado, con unos m\u00e1rgenes de ganancias netas situados entre un 62% y un 76%.\nPor su parte, el informe, que ha estudiado los siete mayores productores privados de vacunas \u2013a las mencionadas anteriormente hay que sumar AstraZeneca, Johnson & Johnson y Novavax\u2013 se\u00f1ala que estas farmac\u00e9uticas recibieron fondos p\u00fablicos por un total de unos 5.800 millones de d\u00f3lares para el desarrollo de inyecciones y medicamentos contra la covid. No obstante, los beneficios de AstraZeneca, Johnson and Johnson y Novavax quedan lejos de las cuatro principales big pharma de la covid: 4.000 millones, 2.400 millones y 1.000 millones, respectivamente. AstraZeneca y la estadounidense Johnson & Johnson se comprometieron a proporcionar sus vacunas sin fines de lucro hasta que la pandemia llegase a su fin.\nEn noviembre de 2021, Oxfam International se\u00f1al\u00f3 que Pfizer, BioNTech y Moderna obtuvieron unas ganancias de 1.000 d\u00f3lares por segundo por sus vacunas covid. Esta estimaci\u00f3n, recoge el estudio de SOMO\n[Pharma\u2019s Pandemic Profits](https://www.somo.nl/topic/pharmaceutical-industry/), se realiz\u00f3 antes de la publicaci\u00f3n de los informes anuales, tras la publicaci\u00f3n de estos las ganancias netas (despu\u00e9s del impuesto sobre la renta) ascendieron a 1.160 d\u00f3lares por segundo, un dividendo que alcanza los 1.630 d\u00f3lares por segundo al agregar los beneficios de Sinovac.\nMiles de millones de fondos p\u00fablicos y APA\nEn medio de la pandemia, asegura el informe del Centro de Investigaciones holand\u00e9s, los gobiernos gastaron miles de millones en fondos para apoyar la investigaci\u00f3n y el desarrollo de vacunas. La financiaci\u00f3n se destin\u00f3 principalmente a ensayos cl\u00ednicos y a la ampliaci\u00f3n de las capacidades de producci\u00f3n. As\u00ed, los siete mayores productores privados de vacunas contra la covid-19 recibieron 5.800 millones de fondos gubernamentales.\nEl Gobierno de EEUU fue, con mucha diferencia, el mayor financiador, otorgando 5.000 millones a las siete compa\u00f1\u00edas mencionadas anteriormente. Estos fondos se proporcionaron bajo el nombre de Operation Warp Speed (OWS), lanzados en mayo de 2020. El reparto fue el siguiente: Moderna (1.700 millones), AstraZeneca (1.ooo millones), Johnson & Johnson (1.000 millones) y Novavax (1.300 millones).\nPfizer no recibi\u00f3 dinero de los fondos OWS. Sin embargo, s\u00ed recibi\u00f3 400 millones del Gobierno alem\u00e1n. Adem\u00e1s, asegura el estudio, tambi\u00e9n se benefici\u00f3 de \u00abdecenas de miles de millones\u00bb de los acuerdos APA (Acuerdos de Compra Anticipada), que proporcionaron a los laboratorios dinero por adelantado, eliminando los riesgos financieros, ya que si la empresa no lograba desarrollar una vacuna que funcionara, el dinero, ya gastado en desarrollo y producci\u00f3n, no ten\u00eda que devolverse. Seg\u00fan este informe, los laboratorios farmac\u00e9uticos recibieron al menos 86.500 millones a trav\u00e9s de estos APA, \u00abuna cifra dif\u00edcil de precisar y que bien podr\u00eda ser mucho mayor porque las empresas y los gobiernos no han sido transparentes\u00bb, asegura.\nOtros gobiernos y organizaciones internacionales tambi\u00e9n han financiado las investigaciones, como la tecnolog\u00eda de ARNm utilizada por Moderna y Pfizer/BioNtech. Por ejemplo, la Fundaci\u00f3n Bill y Melinda Gates financi\u00f3 a Moderna para desarrollar tecnolog\u00eda ARNm por un mont\u00f3n total de 21.000 millones de d\u00f3lares.\nAumento de precios\nEl informe tambi\u00e9n\n[denuncia los aumentos de precios ](https://theobjective.com/espana/politica/2023-04-02/bruselas-renegocia-contratos-vacunas-covid-superavit/)que han ido llevando a cabo las farmac\u00e9uticas a medida que se han ido reduciendo las ventas. Seg\u00fan la Autoridad de Investigaci\u00f3n y Desarrollo Biom\u00e9dico Avanzado (Barda), una oficina del Departamento de Salud y Servicios Humanos (HHS) de EEUU, los precios de las diferentes vacunas escalaron en el tiempo, de los 19 euros por unidad hasta los 30 en el caso de Pfizer/BioNtech, o desde los 16 euros a los 26 en el caso de Moderna.\nAhora, dado que se vender\u00e1n menos vacunas en los pr\u00f3ximos a\u00f1os\n[\u2013el 71,3% de la poblaci\u00f3n mundial ya est\u00e1 vacunada con al menos una dosis\u2013, ](https://covid19-country-overviews.ecdc.europa.eu/vaccination.html)ambas compa\u00f1\u00edas ya han anunciado que cuadriplicar\u00e1n sus precios en un aparente intento por mantener una gran rentabilidad. Pfizer/BioNtech ha fijado un precio por dosis de entre 110 y 130 d\u00f3lares, y Moderna de entre 64 y 100 d\u00f3lares.\nPor \u00faltimo, este centro de investigaciones destaca la desigualdad en cuanto a la distribuci\u00f3n geogr\u00e1fica de las vacunas. Seg\u00fan el sitio web Our World in Data, los principales mercados de Pfizer/BioNTech (67%) y Moderna (26%) han sido EEUU y la Uni\u00f3n Europea. Por su parte, Sinovac gener\u00f3 el 56% de sus ventas en China, mientras que la vacuna de AstraZeneca ha sido dominante en India, con una participaci\u00f3n en el mercado de aproximadamente el 80%. Johnson & Johnson envi\u00f3 m\u00e1s del 80% del suministro global de vacunas contra el coronavius a pa\u00edses de ingresos bajos y medios.", "language": null, "image": "https://theobjective.com/wp-content/uploads/2023/06/pfizer.jpg", "pagetype": "article", "links": ["https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://twitter.com/TheObjective_es", "https://www.instagram.com/theobjective_Es/", "https://www.facebook.com/theobjective.esp", "https://www.youtube.com/c/TheObjective_es", "https://open.spotify.com/user/theobjective_es?si=m4YyKsRFSKaAd11iC1pJrA", "https://es.linkedin.com/company/the-objective-media", "https://medium.com/@TheObjective", "https://www.tiktok.com/@theobjective", "https://theobjective.com/", "https://theobjective.com/espana/", "https://theobjective.com/etiqueta/elecciones-generales/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/castilla-y-leon/", "https://theobjective.com/etiqueta/comunidad-de-madrid/", "https://theobjective.com/etiqueta/comunidad-valenciana/", "https://theobjective.com/etiqueta/pais-vasco/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/cultura/", "https://theobjective.com/etiqueta/literatura/", "https://theobjective.com/etiqueta/musica/", "https://theobjective.com/etiqueta/cine/", "https://theobjective.com/etiqueta/arte/", "https://theobjective.com/etiqueta/series/", "https://theobjective.com/sociedad/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/sociedad/medioambiente/", "https://theobjective.com/lifestyle/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/recetas/", "https://theobjective.com/etiqueta/vinos/", "https://theobjective.com/etiqueta/restaurantes/", "https://theobjective.com/gente/", "https://theobjective.com/etiqueta/celebrities/", "https://theobjective.com/etiqueta/casa-real/", "https://theobjective.com/internacional/", "https://theobjective.com/etiqueta/guerra-ucrania-rusia/", "https://theobjective.com/deportes/", "https://theobjective.com/etiqueta/futbol/", "https://theobjective.com/etiqueta/formula-1/", "https://theobjective.com/etiqueta/baloncesto/", "https://theobjective.com/etiqueta/tenis/", "https://theobjective.com/etiqueta/golf/", "https://theobjective.com/motor/", "https://theobjective.com/etiqueta/coches/", "https://theobjective.com/etiqueta/motos/", "https://theobjective.com/etiqueta/movilidad/", "https://theobjective.com/etiqueta/dgt/", "https://theobjective.com/tecnologia/", "https://theobjective.com/tecnologia/videojuegos/", "https://theobjective.com/etiqueta/internet/", "https://theobjective.com/etiqueta/smartphones/", "https://theobjective.com/etiqueta/redes-sociales/", "https://theobjective.com/etiqueta/historia/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/medios/", "https://theobjective.com/medios/television/", "https://theobjective.com/medios/radio/", "https://theobjective.com/etiqueta/programas/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/videos/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/etiqueta/el-purgatorio/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/podcasts/", "https://theobjective.com/etiqueta/al-tanto/", "https://theobjective.com/etiqueta/el-gris-importa/", "https://theobjective.com/etiqueta/sumario-de-tarde/", "https://theobjective.com/galerias/", "https://theobjective.com/productos-recomendados/", "https://informativoscanarias.theobjective.com/", "https://classpaper.theobjective.com/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/principios-y-valores/", "https://theobjective.com/equipo/", "https://theobjective.com/firmas/", "https://theobjective.com/app/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com/economia/", "https://theobjective.com/economia/", "https://theobjective.com/autor/lidia-ramirez/", "https://theobjective.com/autor/lidia-ramirez/", "https://twitter.com/lidiaramirezrol", "/cdn-cgi/l/email-protection#c7abb5b587b3afa2a8a5ada2a4b3aeb1a2e9a4a8aa", "https://theobjective.com/autor/enrique-morales/", "https://theobjective.com/autor/enrique-morales/", "https://twitter.com/_enriquemorales", "/cdn-cgi/l/email-protection#e88d85a89c808d878a828d8b9c819e8dc68b8785", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Feconomia%2F2023-06-22%2Fcuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Feconomia%2F2023-06-22%2Fcuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas%2F&text=Las%20cuatro%20grandes%20farmac%C3%A9uticas%20de%20la%20covid%20ganaron%2090.000%20millones%20con%20las%20vacunas&via=TheObjective_es", "//web.whatsapp.com/send?text=Las%20cuatro%20grandes%20farmac%C3%A9uticas%20de%20la%20covid%20ganaron%2090.000%20millones%20con%20las%20vacunas | The Objective%20https%3A%2F%2Ftheobjective.com%2Feconomia%2F2023-06-22%2Fcuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Feconomia%2F2023-06-22%2Fcuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas%2F&title=Las%20cuatro%20grandes%20farmac%C3%A9uticas%20de%20la%20covid%20ganaron%2090.000%20millones%20con%20las%20vacunas", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Feconomia%2F2023-06-22%2Fcuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas%2F&text=Las%20cuatro%20grandes%20farmac%C3%A9uticas%20de%20la%20covid%20ganaron%2090.000%20millones%20con%20las%20vacunas%20The Objective", "/cdn-cgi/l/email-protection#2e115d5b4c444b4d5a137a4b0b1c1e5e5b4b4a4b0b1c1e47405a4b5c4b5d4f5c000000084c414a5713624f5d0b1c1e4d5b4f5a5c410b1c1e495c4f404a4b5d0b1c1e484f5c434f4d0b6d1d0b6f175b5a474d4f5d0b1c1e4a4b0b1c1e424f0b1c1e4d4158474a0b1c1e494f404f5c41400b1c1e171e001e1e1e0b1c1e4347424241404b5d0b1c1e4d41400b1c1e424f5d0b1c1e584f4d5b404f5d0b1c1e465a5a5e5d0b1d6f0b1c680b1c685a464b414c444b4d5a47584b004d41430b1c684b4d41404143474f0b1c681c1e1c1d031e18031c1c0b1c684d5b4f5a5c4103495c4f404a4b5d03484f5c434f4d4b5b5a474d4f5d034d4158474a03494f404f5c4140034347424241404b5d03584f4d5b404f5d0b1c68", "https://theobjective.com/espana/politica/2023-04-02/bruselas-renegocia-contratos-vacunas-covid-superavit/", "https://theobjective.com/", "https://www.somo.nl/topic/pharmaceutical-industry/", "https://theobjective.com/espana/politica/2023-04-02/bruselas-renegocia-contratos-vacunas-covid-superavit/", "https://theobjective.com/espana/politica/2023-04-02/bruselas-renegocia-contratos-vacunas-covid-superavit/", "https://theobjective.com/espana/politica/2023-04-02/bruselas-renegocia-contratos-vacunas-covid-superavit/", "https://theobjective.com/espana/2023-02-18/stock-vacunas-covid/", "https://theobjective.com/espana/2023-02-18/stock-vacunas-covid/", "https://covid19-country-overviews.ecdc.europa.eu/vaccination.html", "https://theobjective.com/espana/2023-02-11/vacunas-covid-2023/", "https://theobjective.com/espana/2023-02-11/vacunas-covid-2023/", "https://theobjective.com/autor/lidia-ramirez/", "https://theobjective.com/autor/lidia-ramirez/", "https://twitter.com/lidiaramirezrol", "/cdn-cgi/l/email-protection#8be7f9f9cbffe3eee4e9e1eee8ffe2fdeea5e8e4e6", "https://theobjective.com/autor/lidia-ramirez/", "https://theobjective.com/autor/enrique-morales/", "https://theobjective.com/autor/enrique-morales/", "https://twitter.com/_enriquemorales", "/cdn-cgi/l/email-protection#8feae2cffbe7eae0ede5eaecfbe6f9eaa1ece0e2", "https://theobjective.com/autor/enrique-morales/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Feconomia%2F2023-06-22%2Fcuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Feconomia%2F2023-06-22%2Fcuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas%2F&text=Las%20cuatro%20grandes%20farmac%C3%A9uticas%20de%20la%20covid%20ganaron%2090.000%20millones%20con%20las%20vacunas&via=TheObjective_es", "//web.whatsapp.com/send?text=Las%20cuatro%20grandes%20farmac%C3%A9uticas%20de%20la%20covid%20ganaron%2090.000%20millones%20con%20las%20vacunas | The Objective%20https%3A%2F%2Ftheobjective.com%2Feconomia%2F2023-06-22%2Fcuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Feconomia%2F2023-06-22%2Fcuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas%2F&title=Las%20cuatro%20grandes%20farmac%C3%A9uticas%20de%20la%20covid%20ganaron%2090.000%20millones%20con%20las%20vacunas", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Feconomia%2F2023-06-22%2Fcuatro-grandes-farmaceuticas-covid-ganaron-millones-vacunas%2F&text=Las%20cuatro%20grandes%20farmac%C3%A9uticas%20de%20la%20covid%20ganaron%2090.000%20millones%20con%20las%20vacunas%20The Objective", "/cdn-cgi/l/email-protection#b28dc1c7d0d8d7d1c68fe6d7978082c2c7d7d6d7978082dbdcc6d7c0d7c1d3c09c9c9c94d0ddd6cb8ffed3c1978082d1c7d3c6c0dd978082d5c0d3dcd6d7c1978082d4d3c0dfd3d197f18197f38bc7c6dbd1d3c1978082d6d7978082ded3978082d1ddc4dbd6978082d5d3dcd3c0dddc9780828b829c828282978082dfdbdededddcd7c1978082d1dddc978082ded3c1978082c4d3d1c7dcd3c1978082dac6c6c2c19781f39780f49780f4c6dad7ddd0d8d7d1c6dbc4d79cd1dddf9780f4d7d1dddcdddfdbd39780f4808280819f82849f80809780f4d1c7d3c6c0dd9fd5c0d3dcd6d7c19fd4d3c0dfd3d1d7c7c6dbd1d3c19fd1ddc4dbd69fd5d3dcd3c0dddc9fdfdbdededddcd7c19fc4d3d1c7dcd3c19780f4", "https://news.google.com/publications/CAAiELumQ8m_nwDuO-xzhLPkxhgqFAgKIhC7pkPJv58A7jvsc4Sz5MYY?ceid=ES:es&oc=3", "https://theobjective.com/etiqueta/coronavirus/", "https://theobjective.com/etiqueta/farmaceuticas/", "https://theobjective.com/etiqueta/fondos-publicos/", "https://theobjective.com/etiqueta/moderna/", "https://theobjective.com/etiqueta/novavax/", "https://theobjective.com/etiqueta/pandemias/", "https://theobjective.com/etiqueta/pfizer/", "https://theobjective.com/etiqueta/pfizer-biontech/", "https://theobjective.com/etiqueta/subvenciones/", "https://theobjective.com/etiqueta/vacunas/", "https://theobjective.com/economia/2023-06-21/espana-dispara-exportaciones-hemoderivados-sangre-grifols/", "https://theobjective.com/economia/2023-06-20/lilly-desbanca-johnson-johnson-farmaceutica-valor-bolsa/", "https://theobjective.com/economia/2023-06-09/nuevos-fondos-perte-benefician-sanidad-privada/", "https://theobjective.com/economia/2023-06-13/lilly-reduce-tiempo-fabricacion-nuevos-medicamentos/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/economia/2023-06-06/inflacion-sobrecostes-farmaceuticas/", "https://theobjective.com/economia/2023-06-06/inflacion-sobrecostes-farmaceuticas/", "https://theobjective.com/economia/2023-06-27/faes-farma-china-medicamento-bilastina-urticaria/", "https://theobjective.com/economia/2023-06-27/faes-farma-china-medicamento-bilastina-urticaria/", "https://theobjective.com/economia/2023-06-26/farmacos-obesidad-fenomeno-farmaceuticas/", "https://theobjective.com/economia/2023-06-26/farmacos-obesidad-fenomeno-farmaceuticas/", "https://theobjective.com/economia/2023-06-16/hacienda-plastico/", "https://theobjective.com/economia/2023-06-16/hacienda-plastico/", "https://theobjective.com/espana/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/etiqueta/madrid/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/sociedad/", "https://theobjective.com/cultura/", "https://theobjective.com/deportes/", "https://theobjective.com/internacional/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/lifestyle/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gente/", "https://theobjective.com/videos/", "https://theobjective.com/podcasts/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/branded-content/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/etiqueta/contraluz/", "https://theobjective.com/etiqueta/la-mirilla/", "https://theobjective.com/etiqueta/el-buzon-secreto/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/newsletters/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/politica-de-privacidad/", "https://theobjective.com/politica-de-cookies/", "https://theobjective.com/aviso-legal/", "https://theobjective.com/contactanos/", "https://theobjective.com/newsletters", "https://theobjective.com/terminos-y-condiciones", "https://theobjective.com/politica-de-privacidad", "https://theobjective.com"]}